Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Foletta Mark G
Relationship:   EVP & Chief Financial ...
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   110,179    

Indirect Shares

  62,398      
Direct Value   $1,139,767    

Indirect Value

  $7,947,633      
Total Shares   172,577      
Total Value   $9,087,400      


DexCom Inc
 $378,671 Regulus Therapeutics Inc.
 $165,458 AMN Healthcare Services Inc
 $576,685 Forte Biosciences Inc
 $18,953 DexCom Inc
 $378,671 Regulus Therapeutics Inc.
 $165,458 AMN Healthcare Services Inc
 $576,685 Forte Biosciences Inc
 $18,953
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    1    

     Stock price went up :

    1   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   1.0   
     Percentage Gain/Loss :
   0.7%
 13.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amylin Pharmaceuticals Inc AMLN SVP, Chief Financial O... 2012-08-08 0 2012-08-08 0    Premium*  
            DexCom Inc DXCM Director 2024-05-22 2,973 2024-05-22 62,398    Premium*  
            Regulus Therapeutics Inc. RGLS Director 2017-12-04 81,910 2015-08-13 0    Premium*  
            AMN Healthcare Services Inc AHS Director 2024-04-19 10,254 2016-04-20 0    Premium*  
            Forte Biosciences Inc FBRX EVP & Chief Financial ... 2019-05-28 15,042 2017-04-19 0    Premium*  
* Premium Members only  

Records found :    144         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2008-02-01 4 A $37.00 $6,734 D/D 182 23,753 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-03-30 4 AS $37.61 $94,025 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... VP Finance & CFO   •       –      –    2006-02-15 4 AS $37.70 $56,550 D/D (1,500) 27,048 -
AHS AMN Healthcare Services I... Director   –       •      –    2016-12-15 4 S $37.81 $68,058 D/D (1,800) 3,732 0 -
AMLN Amylin Pharmaceuticals In... officerTitle   •       –      –    2005-12-15 4 AS $38.75 $129,154 D/D (3,333) 26,498 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-02-28 4 AS $38.82 $97,050 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-01-31 4 AS $39.00 $97,500 D/D (2,500) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-11-30 4 AS $40.76 $101,900 D/D (2,500) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-06-29 4 AS $41.38 $103,455 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-08-15 4 AS $41.76 $83,520 D/D (2,000) 21,788 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-04-30 4 AS $42.32 $105,800 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... VP Finance & CFO   •       –      –    2006-05-15 4 AS $42.75 $85,500 D/D (2,000) 21,788 -
AMLN Amylin Pharmaceuticals In... officerTitle   •       –      –    2006-01-17 4 AS $43.00 $86,000 D/D (2,000) 26,498 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-06-15 4 AS $43.00 $86,000 D/D (2,000) 21,788 -
AMLN Amylin Pharmaceuticals In... VP Finance & CFO   •       –      –    2006-03-15 4 AS $43.91 $109,775 D/D (2,500) 27,048 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-10-31 4 AS $43.91 $109,775 D/D (2,500) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-09-15 4 AS $44.35 $88,702 D/D (2,000) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-05-31 4 AS $45.79 $297,663 D/D (6,500) 23,242 0 -
AHS AMN Healthcare Services I... Director   –       •      –    2017-11-27 4 S $47.03 $117,575 D/D (2,500) 3,525 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-07-31 4 AS $47.43 $166,022 D/D (3,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-07-17 4 AS $48.38 $96,765 D/D (2,000) 21,788 -
AMLN Amylin Pharmaceuticals In... VP Finance & CFO   •       –      –    2006-04-17 4 AS $48.84 $97,680 D/D (2,000) 21,788 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-08-31 4 AS $48.86 $146,575 D/D (3,000) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-09-28 4 AS $49.98 $149,932 D/D (3,000) 23,242 0 -
DXCM DexCom Inc Director   –       •      –    2017-11-27 4 S $54.95 $137,386 I/I (2,500) 13,143 0 -

  144  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed